Biotechnology - London, England, United Kingdom
Istesso is a drug discovery and development company working in the field of immunometabolism. Our pipeline of pre-clinical and clinical assets act by reprogramming metabolism to treat autoimmune and inflammatory conditions such as rheumatoid arthritis and multiple sclerosis. Istesso was founded in 2017 as the holding company for Modern Biosciences Ltd.
Outlook
Nginx
Cloudflare DNS
WordPress.org
Mobile Friendly